Sentante Introduces Inflante Digital Indeflator for Endovascular Procedures in Europe

August 3, 2026—Sentante, a medical robotics company developing next-generation endovascular technologies, unveiled its Inflante precision-controlled digital indeflator, which digitizes a critical step in vascular interventions such as angioplasty and stent deployment procedures.

The company advised that Inflante is being developed both as a standalone tool and as part of Sentante’s robotic platform, supporting future remote and semi-autonomous procedures.

The Inflante indeflator has received CE Mark approval in Europe, and the company is progressing through FDA regulatory pathways as a stand-alone device, noted Sentante.

According to the company, Inflante is a digital subsystem that contributes digital pressure control with high-resolution adjustment; real-time feedback and monitoring; and integrated data capture, including pressure profiles, inflation timing, and procedural state to the multimodal data layer that the broader Sentante robotic platform records.

With its digitally controlled interface, the system is intended to replace the traditional manual indeflator—an analog tool and offers digitization, repeatability, and real-time feedback. By reducing manual variability, the system aims to improve outcomes while lowering clinician cognitive load, stated Sentante.